Michael Matson
Stock Analyst
(n/a)
# 4,648
Out of 4,648 analysts
20
Total ratings
n/a
Success rate
n/a
Average return
Main Sectors:
Stocks Rated by Michael Matson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TFX Teleflex | Maintains: Buy | $408 → $423 | $207.33 | +104.02% | 4 | Jan 31, 2020 | |
| INGN Inogen | Upgrades: Buy | $90 | $9.03 | +896.68% | 2 | Nov 6, 2019 | |
| MMSI Merit Medical Systems | Initiates: Buy | $53 | $99.08 | -46.51% | 1 | Apr 20, 2018 | |
| GMED Globus Medical | Upgrades: Buy | n/a | $74.72 | - | 1 | Apr 4, 2018 | |
| RMD ResMed | Upgrades: Hold | n/a | $243.61 | - | 1 | Jan 23, 2018 | |
| BSX Boston Scientific | Upgrades: Strong Buy | n/a | $84.72 | - | 1 | Dec 8, 2017 | |
| LIVN LivaNova | Upgrades: Buy | n/a | $49.01 | - | 2 | Sep 15, 2017 | |
| SYK Stryker | Upgrades: Hold | n/a | $366.90 | - | 4 | Aug 25, 2017 | |
| MBLY Mobileye | Downgrades: Hold | n/a | $14.57 | - | 1 | Mar 14, 2017 | |
| HOLX Hologic | Upgrades: Buy | n/a | $83.72 | - | 2 | Feb 15, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $1.66 | - | 1 | Feb 24, 2016 |
Teleflex
Jan 31, 2020
Maintains: Buy
Price Target: $408 → $423
Current: $207.33
Upside: +104.02%
Inogen
Nov 6, 2019
Upgrades: Buy
Price Target: $90
Current: $9.03
Upside: +896.68%
Merit Medical Systems
Apr 20, 2018
Initiates: Buy
Price Target: $53
Current: $99.08
Upside: -46.51%
Globus Medical
Apr 4, 2018
Upgrades: Buy
Price Target: n/a
Current: $74.72
Upside: -
ResMed
Jan 23, 2018
Upgrades: Hold
Price Target: n/a
Current: $243.61
Upside: -
Boston Scientific
Dec 8, 2017
Upgrades: Strong Buy
Price Target: n/a
Current: $84.72
Upside: -
LivaNova
Sep 15, 2017
Upgrades: Buy
Price Target: n/a
Current: $49.01
Upside: -
Stryker
Aug 25, 2017
Upgrades: Hold
Price Target: n/a
Current: $366.90
Upside: -
Mobileye
Mar 14, 2017
Downgrades: Hold
Price Target: n/a
Current: $14.57
Upside: -
Hologic
Feb 15, 2017
Upgrades: Buy
Price Target: n/a
Current: $83.72
Upside: -
Feb 24, 2016
Downgrades: Hold
Price Target: n/a
Current: $1.66
Upside: -